Related Experiment Videos
Evolving trends in infective endocarditis.
E E Hill1, P Herijgers, M-C Herregods
1Department of Internal Medicine - Infectious Diseases, University Hospital Gasthuisberg, 3000 Leuven, Belgium.
Summary
Infective endocarditis (IE) management has evolved, with prosthetic valves and Staphylococcus infections rising. Elderly patients with degenerative valve disease are most at risk, highlighting areas for further research in IE treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Microbiology
Background:
- Infective endocarditis (IE) remains a high-mortality condition despite advances in diagnosis and treatment.
- The past two decades have seen significant shifts in IE epidemiology, microbiology, and management strategies.
- Understanding these changes is crucial for improving patient outcomes.
Purpose of the Study:
- To review the evolving landscape of infective endocarditis over the last 20 years.
- To analyze changes in epidemiology, microbiology, diagnosis, and medical/surgical management.
- To identify areas requiring further investigation in IE care.
Main Methods:
- Comprehensive literature review focusing on studies from the past two decades.
- Analysis of trends in causative agents, affected populations, and disease acquisition.
- Evaluation of current diagnostic and therapeutic approaches for native and prosthetic valve endocarditis.
Main Results:
- Increased incidence of prosthetic valve endocarditis and nosocomial infections.
- Predominance of Staphylococcus species as causative agents.
- Elderly individuals with degenerative valvular disease identified as a highly vulnerable group.
Conclusions:
- IE management requires ongoing adaptation due to changing epidemiological and microbiological patterns.
- Further research is needed to optimize antimicrobial therapies and surgical timing.
- Predicting complications like embolisation and perivalvular issues requires further study.